are able to reprogram tumor cells, turning them into functional cDC1s, which are more effective than other DC subtypes at cross-presenting antigens and inducing antigen-specific T cell responses.

The other approach involves injecting dendritic cells expressing tumor-associated antigens subcutaneously, to prevent cancer relapse through a vaccination approach (Fig. 1). “The principle ...

[5] The target antigen to be chosen in this strategy should have a limited expression in normal tissues, as even low expression in normal tissues can cause cytotoxicity or lethality. Tumor ...

Supervised Exercise for Patients With Metastatic Breast Cancer: A Cost-Utility Analysis Alongside the PREFERABLE-EFFECT Randomized ... patients with metastatic CRC often face limited options and poor ...